These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20452051)

  • 1. The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review.
    Hempel RJ; Dekker JA; van Beveren NJ; Tulen JH; Hengeveld MW
    Psychiatry Res; 2010 Jun; 178(1):1-9. PubMed ID: 20452051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic medication and social cue recognition in chronic schizophrenia.
    Roberts DL; Penn DL; Corrigan P; Lipkovich I; Kinon B; Black RA
    Psychiatry Res; 2010 Jun; 178(1):46-50. PubMed ID: 20452678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study.
    Fakra E; Salgado-Pineda P; Besnier N; Azorin JM; Blin O
    World J Biol Psychiatry; 2009; 10(4 Pt 3):719-28. PubMed ID: 17853271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial recognition deficits and cognition in schizophrenia.
    Sachs G; Steger-Wuchse D; Kryspin-Exner I; Gur RC; Katschnig H
    Schizophr Res; 2004 May; 68(1):27-35. PubMed ID: 15037337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired recognition of happy, sad and neutral expressions in schizophrenia is emotion, but not valence, specific and context dependent.
    Silver H; Bilker W; Goodman C
    Psychiatry Res; 2009 Sep; 169(2):101-6. PubMed ID: 19692127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program.
    Wölwer W; Frommann N; Halfmann S; Piaszek A; Streit M; Gaebel W
    Schizophr Res; 2005 Dec; 80(2-3):295-303. PubMed ID: 16125367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Face and body perception in schizophrenia: a configural processing deficit?
    Soria Bauser D; Thoma P; Aizenberg V; Brüne M; Juckel G; Daum I
    Psychiatry Res; 2012 Jan; 195(1-2):9-17. PubMed ID: 21803427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First rank symptoms & facial emotion recognition deficits in antipsychotic naïve schizophrenia: Implications for social threat perception model.
    Behere RV; Venkatasubramanian G; Arasappa R; Reddy NN; Gangadhar BN
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1653-8. PubMed ID: 21651952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia.
    Satterthwaite TD; Wolf DH; Loughead J; Ruparel K; Valdez JN; Siegel SJ; Kohler CG; Gur RE; Gur RC
    Am J Psychiatry; 2010 Apr; 167(4):418-26. PubMed ID: 20194482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emotion recognition, 'theory of mind,' and social behavior in schizophrenia.
    Brüne M
    Psychiatry Res; 2005 Feb; 133(2-3):135-47. PubMed ID: 15740990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential brain activation during facial emotion discrimination in first-episode schizophrenia.
    Reske M; Habel U; Kellermann T; Backes V; Jon Shah N; von Wilmsdorff M; Gaebel W; Zilles K; Schneider F
    J Psychiatr Res; 2009 Mar; 43(6):592-9. PubMed ID: 19056093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eye movement during facial affect recognition by patients with schizophrenia, using Japanese pictures of facial affect.
    Shiraishi Y; Ando K; Toyama S; Norikane K; Kurayama S; Abe H; Ishida Y
    Percept Mot Skills; 2011 Oct; 113(2):409-20. PubMed ID: 22185055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
    Burton S
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
    Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
    Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophrenia.
    Norton D; McBain R; Holt DJ; Ongur D; Chen Y
    Biol Psychiatry; 2009 Jun; 65(12):1094-8. PubMed ID: 19268917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From neuroleptics to antipsychotics: the cognitive and emotional impact].
    Blin O; Fakra E; Tardieu S; Micallef J
    Encephale; 2002; 28 Spec No 2 Pt 2():S16-8. PubMed ID: 12587350
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates.
    Johnston PJ; Stojanov W; Devir H; Schall U
    Eur J Neurosci; 2005 Sep; 22(5):1221-32. PubMed ID: 16176365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and diagnostic subtype in facial affect recognition in schizophrenia.
    Lewis SF; Garver DL
    J Psychiatr Res; 1995; 29(1):5-11. PubMed ID: 7629755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.